| Secondary |
| Upper Respiratory Tract Inflammation |
14.9% |
| Duodenal Ulcer |
13.9% |
| Spinal Compression Fracture |
9.3% |
| Bronchitis |
9.0% |
| Asthma |
7.1% |
| Hyperlipidaemia |
5.3% |
| Osteoporosis |
4.6% |
| Hypertension |
4.0% |
| Lymphadenitis |
3.7% |
| Pharyngitis |
3.4% |
| Pneumonia |
3.1% |
| Prophylaxis |
3.1% |
| Bronchopulmonary Aspergillosis |
2.5% |
| Cough |
2.5% |
| Mycoplasma Infection |
2.5% |
| Oropharyngeal Pain |
2.5% |
| Pneumonia Bacterial |
2.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Enterocolitis |
1.9% |
| Nasopharyngitis |
1.9% |
|
| Pyrexia |
18.6% |
| Hepatic Function Abnormal |
11.9% |
| Interstitial Lung Disease |
8.5% |
| Cholecystitis |
5.1% |
| Pleural Effusion |
5.1% |
| Pneumonia |
5.1% |
| Drug Eruption |
3.4% |
| Eczema |
3.4% |
| Hepatitis Fulminant |
3.4% |
| Loss Of Consciousness |
3.4% |
| Lung Infiltration |
3.4% |
| Mouth Ulceration |
3.4% |
| Pneumonitis |
3.4% |
| Rash |
3.4% |
| Sinus Arrest |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Stomatitis |
3.4% |
| Swelling Face |
3.4% |
| Vertigo |
3.4% |
| Atrioventricular Block Second Degree |
1.7% |
|
| Concomitant |
| Prophylaxis |
18.8% |
| Product Used For Unknown Indication |
16.6% |
| Infection Prophylaxis |
8.0% |
| Prophylaxis Against Graft Versus Host Disease |
5.8% |
| Hypertension |
5.3% |
| Psoriatic Arthropathy |
5.3% |
| Pneumonia |
4.8% |
| Asthma |
4.0% |
| Acute Myeloid Leukaemia |
3.8% |
| Pharyngitis |
3.3% |
| Multiple Myeloma |
3.0% |
| Bone Marrow Conditioning Regimen |
2.8% |
| Constipation |
2.8% |
| Bronchitis |
2.5% |
| Emphysema |
2.5% |
| Insomnia |
2.5% |
| Mantle Cell Lymphoma |
2.5% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii Stage Iv |
2.0% |
| Hiv Infection |
2.0% |
| Interstitial Lung Disease |
1.8% |
|
| Liver Disorder |
12.2% |
| Pyrexia |
12.2% |
| Interstitial Lung Disease |
10.2% |
| Hepatic Function Abnormal |
8.2% |
| Pneumonia |
8.2% |
| Hypokalaemia |
6.1% |
| Acute Graft Versus Host Disease In Skin |
4.1% |
| Brain Stem Haemorrhage |
4.1% |
| Chronic Myeloid Leukaemia Transformation |
4.1% |
| Hypernatraemia |
4.1% |
| Lung Disorder |
4.1% |
| Sepsis |
4.1% |
| Sideroblastic Anaemia |
4.1% |
| Abdominal Pain Upper |
2.0% |
| Activation Syndrome |
2.0% |
| Akathisia |
2.0% |
| Alanine Aminotransferase Increased |
2.0% |
| Bronchitis |
2.0% |
| Cardiac Failure |
2.0% |
| Cardiac Failure Congestive |
2.0% |
|
